BIODESIX INC Quarterly Interest Expense in USD from Q3 2019 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Biodesix Inc quarterly/annual Interest Expense history and growth rate from Q3 2019 to Q2 2024.
Biodesix Inc Interest Expense for the quarter ending June 30, 2024 was $1.94M, a 20.3% decline year-over-year.
Biodesix Inc Interest Expense for the twelve months ending June 30, 2024 was $9.18M, a 11.8% decline year-over-year.
Biodesix Inc annual Interest Expense for 2023 was $9.54M, a 18.1% increase from 2022.
Biodesix Inc annual Interest Expense for 2022 was $8.07M, a 79.1% increase from 2021.
Biodesix Inc annual Interest Expense for 2021 was $4.51M, a 40.7% decline from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	$9.18M	$1.94M	-$494K	-20.3%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$9.67M	$2.53M	+$138K	+5.77%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$9.54M	$2.33M	-$221K	-8.67%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-01
Q3 2023	$9.76M	$2.39M	-$653K	-21.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$10.4M	$2.43M	+$1.08M	+80.5%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$9.33M	$2.39M	+$1.25M	+110%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q4 2022	$8.07M	$2.55M	+$1.05M	+70.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-01
Q3 2022	$7.02M	$3.04M	+$1.49M	+96.6%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	$5.53M	$1.35M	+$531K	+65.2%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-07
Q1 2022	$4.99M	$1.14M	+$486K	+74.7%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$4.51M	$1.5M	+$791K	+112%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-06
Q3 2021	$3.72M	$1.55M	-$1.11M	-41.8%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	$4.83M	$815K	-$1.97M	-70.7%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$6.8M	$651K	-$806K	-55.3%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	$7.6M	$705K			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-14
Q3 2020		$2.66M	+$1.95M	+276%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020		$2.78M			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-10
Q1 2020		$1.46M			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-11
Q3 2019		$706K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-12-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.